We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Lonza Expands Singapore Bioservices
News

Lonza Expands Singapore Bioservices

Lonza Expands Singapore Bioservices
News

Lonza Expands Singapore Bioservices

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Lonza Expands Singapore Bioservices"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Lonza is investing nearly $12 million to expand its biopharmaceutical development services in Singapore. Lonza’s Development Services business provides customized services for the development of robust biomanufacturing processes.

The expansion will add 1,858 m² of lab space and associated equipment, and will support cell line construction, upstream and downstream process development, and a broad range of analytical services.

Lonza currently offers these services in its Slough, UK facility with a limited offering in Singapore. The facility is expected to come on-line in by mid-2012.

“This further investment in our Singapore location is driven by the increased demand we are seeing on a global basis,” said Janet White, head of development services at Lonza.

“We are looking forward to offering the full range of our GS Gene Expression System and other technologies in Asia. The location is advantageous to many of our customers from across the globe, and in particular, with our growing set of customers based in the region.”

Advertisement